A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

It’s not yet known how many people have gotten sick in the Texas measles outbreak, but there are at least 215 confirmed cases since late January.

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...

During the first address to Congress of his second term this week, President Donald Trump bragged about the accomplishments ...

There is no disagreement that foreign aid makes a difference; more resources are needed, not less. An estimated US$22 billion ...